- Home
- UTHR vs BAP Comparison
UTHR vs BAP Comparison
Compare UTHR & BAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- BAP
- Stock Information
- Founded
- UTHR 1996
- BAP 1889
- Country
- UTHR United States
- BAP Peru
- Employees
- UTHR N/A
- BAP N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- BAP Major Banks
- Sector
- UTHR Health Care
- BAP Finance
- Exchange
- UTHR Nasdaq
- BAP Nasdaq
- Market Cap
- UTHR 16.2B
- BAP 14.7B
- IPO Year
- UTHR 1999
- BAP 1995
- Fundamental
- Price
- UTHR $359.23
- BAP $182.22
- Analyst Decision
- UTHR Buy
- BAP Hold
- Analyst Count
- UTHR 14
- BAP 4
- Target Price
- UTHR $370.86
- BAP $194.25
- AVG Volume (30 Days)
- UTHR 313.6K
- BAP 320.0K
- Earning Date
- UTHR 02-19-2025
- BAP 02-10-2025
- Dividend Yield
- UTHR N/A
- BAP 2.11%
- EPS Growth
- UTHR 25.10
- BAP 3.65
- EPS
- UTHR 22.72
- BAP 17.61
- Revenue
- UTHR $2,756,200,000.00
- BAP $4,667,680,981.00
- Revenue This Year
- UTHR $26.32
- BAP N/A
- Revenue Next Year
- UTHR $10.37
- BAP $7.21
- P/E Ratio
- UTHR $15.82
- BAP $10.34
- Revenue Growth
- UTHR 25.04
- BAP 8.67
- 52 Week Low
- UTHR $208.62
- BAP $144.22
- 52 Week High
- UTHR $417.82
- BAP $200.00
- Technical
- Relative Strength Index (RSI)
- UTHR 43.90
- BAP 40.37
- Support Level
- UTHR $358.82
- BAP $179.67
- Resistance Level
- UTHR $383.00
- BAP $187.15
- Average True Range (ATR)
- UTHR 9.97
- BAP 5.00
- MACD
- UTHR -0.80
- BAP -1.48
- Stochastic Oscillator
- UTHR 29.51
- BAP 15.14
About UTHR United Therapeutics Corporation
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
About BAP Credicorp Ltd.
Credicorp Ltd is a Peruvian financial services company. It operates in four business lines including Universal Banking, Insurance and Pensions, Microfinance, and Investment Management & Advisory. Its subsidiaries include Banco de Credito del Peru, Prima AFP, and Credicorp Capital.